Garry Pairaudeau
Directeur Technique/Scientifique/R&D chez Exscientia AI Ltd.
Postes actifs de Garry Pairaudeau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/11/2020 | - |
Historique de carrière de Garry Pairaudeau
Anciens postes connus de Garry Pairaudeau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EXSCIENTIA PLC | Directeur Technique/Scientifique/R&D | 01/11/2020 | 30/06/2023 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2014 | 01/11/2020 |
Formation de Garry Pairaudeau
| The University of Southampton | Doctorate Degree |
Statistiques
Internationale
| Royaume-Uni | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Garry Pairaudeau
- Expérience
